Artificial Blood Substitutes Market Report and Patent Landscape Analysis
Artificial blood Substitute is an artificially developed substitute for red blood cells which is use for transporting oxygen and nutrients to the body cells and transporting back carbon dioxide, ammonia, and other waste products away from cells. Artificial blood substitutes are being researched and developed as alternatives for replacing RBCs for oxygen carrying capacity. Artificial blood are substance used to mimic and fulfill some functions of biological blood. The study provides information on the global supply and demand for human blood, the constraints associated with the supply, the market need to develop artificial blood substitutes, limitations associated with artificial blood substitute development.
This report aims to present business and patent landscape for the emerging market of artificial blood substitutes. The objective is to analyze existing technologies and emerging trends in each aspect of the industry.The study presents a detailed analysis of research activities in Artificial blood substitutes industry along with significant patent data trends and analysis. Artificial blood products market has been analyzed based on various attributes such as:
First, by Source (human blood, animal blood, microorganism based recombinant Hb, synthetic polymers, stem cells) from which blood substitutes are derived. Second, by Product type (PFCs, HBOCs). Third, by Application (Cardiovascular diseases, Malignant neoplasms, Injuries, Neonatal Conditions, Organ transplants, Maternal condition. Forth, by Patent Activities (patent categories and classification, patent landscape analysis, licensing and litigation). Six potential application markets have been identified based on the possibility of replacing donor blood in critical medical treatments:
- Cardiovascular diseases
- Malignant neoplasms
- Neonatal Conditions
- Organ transplants
- Maternal condition
The market growth for each application segment have been predicted further for the period 2022 to 2027. Number of artificial blood units required for blood transfusion in each of the six categories of medical treatment cases have been assumed based on the current average number of donor blood units used for transfusion procedures in these categories.
Report also focus on competitor landscape with product profiling, projected global potential market size for artificial blood substitutes regarding both volume and value for 2022 and 2027, forecasted market penetration scenarios including market impacting factors. In-depth company profiling of active as well as inactive companies and their products have been included in this report. Regional dynamics of the global artificial blood market and current trends within the industry have been deliberated in the report. The major Key players are Alliance Pharmaceutical Corp., Baxter Healthcare Corp., Nuvox Pharmaceuticals, Sanguine Inc., and Therapure Biopharma are the active players in the artificial blood products market and they are endeavoring to win a significant share of the market through new production methodologies, front-line advancements, and new items.
Request for sample pdf of Artificial Blood Substitutes Market Report here